Ciara Kelly, MBBCh BAO
Sarcoma Medical Oncologist
My Role at MSKWe post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
Request an Appointment
About Me
- Interim Clinical Director, Sarcoma Oncology Service
I am a medical oncologist who has expertise in treating and researching bone and soft tissue sarcomas and merkel cell carcinoma. I work very closely with our team of medical oncologists, surgeons, radiation oncologists, nurses, and patient support advocates. We provide our patients with the best care and treatment options for their unique disease and circumstances.
My research aims to develop new and more personalized therapies to treat sarcomas. I am actively involved in developing and designing clinical trials that will look at novel agents that target molecular changes within tumors. I am also studying innovative combination immunotherapy options that will harness a person’s own immune defenses to fight their cancer. I have a particular interest in advancing our understanding of gastrointestinal stromal tumors and other sarcomas at the molecular level. I am using liquid biopsies to analyze tumor DNA in the blood and tumor biopsies to uncover a biomarker that will ultimately help us match the best treatment option with each individual person’s tumor. When someone is diagnosed with a rare cancer like a sarcoma, they may think there are limited treatment options. At MSK, the rare is not uncommon. We have an entire team of experts who are solely focused on diagnosing and treating sarcomas. We are constantly looking for newer and better ways to care for our patients.
A sarcoma medical oncologist is a cancer doctor who specializes in sarcoma. This includes soft tissue sarcomas (such as Ewing sarcoma and rhabdomyosarcoma) and benign (not cancer) growths that are like sarcoma.
My Specialties
- Bone and Soft Tissue Sarcomas
- Merkel Cell Carcinoma
Education
- MBBCh BAO, University College Dublin
Residencies
- Internal medicine – The Royal College of Physicians of Ireland
Awards and Honors
- Irish Society of Medical Oncology Scholarship Award (2014)
- American Society of Clinical Oncology (ASCO) Merit Award (2017)
- ASCO Young Investigator Award (2017)
Fellowships
- Medical Oncology – The Royal College of Physicians Ireland
- Medical Oncology - Memorial Sloan Kettering Cancer Center
Board Certifications
- Internal Medicine (Ireland)
- Medical Oncology (Ireland & Europe)
Insurance Information
Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.
In Network Coverage Type
HMO, PPO
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
HMO, EPO PPO, POS
In Network Coverage Type
PPO, POS, EPO, HMO
Offers a qualified health plan from the Health Insurance Marketplace. Call Emblem to learn more.
In Network Coverage Type
PPO, HMO
In Network Coverage Type
PPO, HMO, DSN
In Network Coverage Type
PPO
In Network Coverage Type
HMO, EPO
Offers a qualified health plan from the Health Insurance Marketplace. Call Fidelis to learn more.
In Network Coverage Type
EPO, HMO, PPO, POS
Offers a qualified health plan from the Health Insurance Marketplace. Call Healthfirst to learn more.
In Network Coverage Type
HMO
In Network Coverage Type
PPO
In Network Coverage Type
EPO
In Network Coverage Type
EPO
In Network Coverage Type
Federal Government
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
State Government
Don't see your carrier or plan? We can help you understand your coverage.
If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.
If you have questions about insurance, call us at 646-497-9176.
Make an Appointment
New Patients
Current Patients
Contact and Location
Dr. Kelly sees patients at two locations.
Looking to see a doctor at a different location? See all MSK locations.
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Clinical Trials
- Clinical Trials Investigated by Dr. Kelly
- A Phase 1 Study of CRD3874-SI in People With Advanced Sarcoma or Merkel Cell Cancer
- A Phase 1 Study of IDRX-42 in People With Gastrointestinal Stromal Tumors
- A Phase II Study of AG-120 for Patients with IDH1-Mutant Chondrosarcoma
- A Phase II Study of INBRX-109 for Inoperable or Metastatic Chondrosarcoma
Read more
- Clinical Trials Co-Investigated by Dr. Kelly
- A Phase 1/2 Study of DCC-3116 Plus Ripretinib for People with Advanced Gastrointestinal Stromal Tumor
- A Phase 2 Study of Tigilanol Tiglate in People With Soft Tissue Sarcoma
- A Phase 3 Study of Ivosidenib in People With Conventional Chondrosarcoma
- A Phase 3 Study of Ripretinib Versus Sunitinib in People With Advanced GIST Tumors With Certain Genetic Changes
- A Phase I Study of NB003 in People with Gastrointestinal Stromal Tumor or Another Solid Tumor
- A Phase II Study of ASTX727 in People with Malignant Peripheral Nerve Sheath Tumors
- A Phase II Study of Radiation Therapy with or without Avelumab in People with Advanced Merkel Cell Carcinoma
- A Phase III Study of Sunitinib with or without CGT9486 in People with Inoperable or Metastatic Gastrointestinal Stromal Tumors
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
Visit PubMed for a full listing of Dr. Kelly’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
See all on PubMedPatient Reviews
Your trust is our main concern
We strive to keep reviews trustworthy, honest and fair. Learn more about our patient experience reviews.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Ciara Kelly discloses the following relationships and financial interests:
-
ChemoCentryx, Inc.
Professional Services and Activities -
Deciphera
Professional Services and Activities -
Exicure, Inc.
Professional Services and Activities
-
Kartos Therapeutics, Inc.
Professional Services and Activities (Uncompensated) -
Physicians' Education Resource
Professional Services and Activities
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].